Works matching IS 08876924 AND DT 2011 AND VI 25 AND IP 7

Results: 28

The MEK inhibitor PD184352 enhances BMS-214662-induced apoptosis in CD34+ CML stem/progenitor cells.

Published in:

2011

By:

Pellicano, F.;
Šimara, P.;
Sinclair, A.;
Helgason, G. V.;
Grant, M.;
Copland, M.;
Holyoake, T. L.;
Simara, P;
Grant, S

Publication type:

journal article

Backtracking to birth of the NUP98-HOXD13 gene fusion in an infant acute myeloid leukemia.

Published in:

2011

By:

Emerenciano, M.;
Meyer, C.;
Macedo-Silva, M. L.;
de Meis, E.;
Dobbin, J. A.;
Marschalek, R.;
Pombo-de-Oliveira, M. S.

Publication type:

Letter

Acute lymphoblastic leukemia cells treated with CpG oligodeoxynucleotides, IL-4 and CD40 ligand facilitate enhanced anti-leukemic CTL responses.

Published in:

Leukemia (08876924), 2011, v. 25, n. 7, p. 1111, doi. 10.1038/leu.2011.87

By:

Fabricius, D.;
Breckerbohm, L.;
Vollmer, A.;
Queudeville, M.;
Eckhoff, S. M.;
Fulda, S.;
Strauss, G.;
Debatin, K.-M.;
Jahrsdörfer, B.;
Meyer, L. H.

Publication type:

Article

Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine.

Published in:

2011

By:

Itzykson, R.;
Thépot, S.;
Eclache, V.;
Quesnel, B.;
Dreyfus, F.;
Beyne-Rauzy, O.;
Turlure, P.;
Vey, N.;
Recher, C.;
Boehrer, S.;
Gardin, C.;
Adès, L.;
Fenaux, P.

Publication type:

Letter

Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias.

Published in:

2011

By:

Itzykson, R.;
Kosmider, O.;
Cluzeau, T.;
Mansat-De Mas, V.;
Beyne-Rauzy, F.;
Quesnel, B.;
Vey, N.;
Gelsi-Boyer, V.;
Raynaud, S.;
Preudhomme, C.;
Adès, L.;
Fenaux, P.;
Fontenay, M.;
Beyne-Rauzy, O.;
Dreyfus, F.;
Adès, L;
Groupe Francophone des Myelodysplasies (GFM)

Publication type:

journal article

Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms.

Published in:

2011

By:

Abdel-Wahab, O.;
Pardanani, A.;
Patel, J.;
Wadleigh, M.;
Lasho, T.;
Heguy, A.;
Beran, M.;
Gilliland, D. G.;
Levine, R. L.;
Tefferi, A.

Publication type:

Letter

The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells.

Published in:

2011

By:

Asano, J.;
Nakano, A.;
Oda, A.;
Amou, H.;
Hiasa, M.;
Takeuchi, K.;
Miki, H.;
Nakamura, S.;
Harada, T.;
Fujii, S.;
Kagawa, K.;
Endo, I.;
Yata, K.;
Sakai, A.;
Ozaki, S.;
Matsumoto, T.;
Abe, M.

Publication type:

journal article

The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcome.

Published in:

2011

By:

Burnett, A. K.;
Hills, R. K.;
Hunter, A.;
Milligan, D.;
Kell, J.;
Wheatley, K.;
Yin, J.;
McMullin, M.-F.;
Cahalin, P.;
Craig, J.;
Bowen, D.;
Russell, N.

Publication type:

journal article

Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.

Published in:

Leukemia (08876924), 2011, v. 25, n. 7, p. 1128, doi. 10.1038/leu.2011.78

By:

Lehmann, S.;
Ravn, A.;
Carlsson, L.;
Antunovic, P.;
Deneberg, S.;
Möllgård, L.;
Rangert Derolf, Å;
Stockelberg, D.;
Tidefelt, U.;
Wahlin, A.;
Wennström, L.;
Höglund, M.;
Juliusson, G.

Publication type:

Article

Recurrent DNMT3A mutations in patients with myelodysplastic syndromes.

Published in:

2011

By:

Walter, M. J.;
Ding, L.;
Shen, D.;
Shao, J.;
Grillot, M.;
McLellan, M.;
Fulton, R.;
Schmidt, H.;
Kalicki-Veizer, J.;
O'Laughlin, M.;
Kandoth, C.;
Baty, J.;
Westervelt, P.;
DiPersio, J. F.;
Mardis, E. R.;
Wilson, R. K.;
Ley, T. J.;
Graubert, T. A.

Publication type:

journal article

Evaluating the clonal hierarchy in light-chain multiple myeloma: implications against the myeloma stem cell hypothesis.

Published in:

2011

By:

Pfeifer, S.;
Perez-Andres, M.;
Ludwig, H.;
Sahota, S. S.;
Zojer, N.

Publication type:

Letter

DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms.

Published in:

2011

By:

Abdel-Wahab, O.;
Pardanani, A.;
Rampal, R.;
Lasho, T. L.;
Levine, R. L.;
Tefferi, A.

Publication type:

Letter

Smac mimetics: implications for enhancement of targeted therapies in leukemia.

Published in:

2011

By:

Weisberg, E.;
Ray, A.;
Barrett, R.;
Nelson, E.;
Christie, A. L.;
Porter, D.;
Straub, C.;
Zawel, L.;
Daley, J. F.;
Lazo-Kallanian, S.;
Stone, R.;
Galinsky, I.;
Frank, D.;
Kung, A. L.;
Griffin, J. D.

Publication type:

Correction Notice

A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function.

Published in:

2011

By:

Vallet, S.;
Pozzi, S.;
Patel, K.;
Vaghela, N.;
Fulciniti, M. T.;
Veiby, P.;
Hideshima, T.;
Santo, L.;
Cirstea, D.;
Scadden, D. T.;
Anderson, K. C.;
Raje, N.

Publication type:

journal article

DNMT3A mutations in myeloproliferative neoplasms.

Published in:

2011

By:

Stegelmann, F.;
Bullinger, L.;
Schlenk, R. F.;
Paschka, P.;
Griesshammer, M.;
Blersch, C.;
Kuhn, S.;
Schauer, S.;
Döhner, H.;
Döhner, K.

Publication type:

Letter

Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy.

Published in:

2011

By:

Steelman, L. S.;
Franklin, R. A.;
Abrams, S. L.;
Chappell, W.;
Kempf, C. R.;
Bäsecke, J.;
Stivala, F.;
Donia, M.;
Fagone, P.;
Nicoletti, F.;
Libra, M.;
Ruvolo, P.;
Ruvolo, V.;
Evangelisti, C.;
Martelli, A. M.;
McCubrey, J. A.;
Bäsecke, J

Publication type:

journal article

Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.

Published in:

2011

By:

Martelli, A. M.;
Evangelisti, C.;
Chappell, W.;
Abrams, S. L.;
Bäsecke, J.;
Stivala, F.;
Donia, M.;
Fagone, P.;
Nicoletti, F.;
Libra, M.;
Ruvolo, V.;
Ruvolo, P.;
Kempf, C. R.;
Steelman, L. S.;
McCubrey, J. A.;
Bäsecke, J

Publication type:

journal article

Allogeneic stem cell transplant to eliminate germline mutations in the gene for CCAAT-enhancer-binding protein α from hematopoietic cells in a family with AML.

Published in:

2011

By:

Stelljes, M.;
Corbacioglu, A.;
Schlenk, R. F.;
Döhner, K.;
Frühwald, M. C.;
Rossig, C.;
Ehlert, K.;
Silling, G.;
Müller-Tidow, C.;
Juergens, H.;
Döhner, H.;
Berdel, W. E.;
Kienast, J.;
Koschmieder, S.

Publication type:

Letter

Development of standardized approaches to reporting of minimal residual disease data using a reporting software package designed within the European LeukemiaNet.

Published in:

Leukemia (08876924), 2011, v. 25, n. 7, p. 1168, doi. 10.1038/leu.2011.69

By:

Østergaard, M.;
Nyvold, C. G.;
Jovanovic, J. V.;
Andersen, M. T.;
Kairisto, V.;
Morgan, Y. G.;
Tobal, K.;
Pallisgaard, N.;
Özbek, U.;
Pfeifer, H.;
Schnittger, S.;
Grubach, L.;
Larsen, J. K.;
Grimwade, D.;
Hokland, P.

Publication type:

Article

High-resolution genomic profiling in hairy cell leukemia-variant compared with typical hairy cell leukemia.

Published in:

2011

By:

Hockley, S. L.;
Morgan, G. J.;
Leone, P. E.;
Walker, B. A.;
Morilla, A.;
Else, M.;
Wotherspoon, A.;
Dearden, C.;
Catovsky, D.;
Gonzalez, D.;
Matutes, E.

Publication type:

Letter

GSI-I (Z-LLNle-CHO) inhibits γ-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia.

Published in:

2011

By:

Meng, X.;
Matlawska-Wasowska, K.;
Girodon, F.;
Mazel, T.;
Willman, C. L.;
Atlas, S.;
Chen, I.-M.;
Harvey, R. C.;
Hunger, S. P.;
Ness, S. A.;
Winter, S. S.;
Wilson, B. S.

Publication type:

journal article

Effect of ligand-activated estrogen receptor β on lymphoma growth in vitro and in vivo.

Published in:

2011

By:

Yakimchuk, K.;
Iravani, M.;
Hasni, M. S.;
Rhönnstad, P.;
Nilsson, S.;
Jondal, M.;
Okret, S.;
Rhönnstad, P

Publication type:

journal article

Stem cell self-renewal: lessons from bone marrow, gut and iPS toward clinical applications.

Published in:

Leukemia (08876924), 2011, v. 25, n. 7, p. 1095, doi. 10.1038/leu.2011.52

By:

Staal, F. J. T.;
Cowan, C.;
Dzierzak, E.;
Hacein-Bey-Abina, S.;
Karlsson, S.;
Lapidot, T.;
Lemischka, I.;
Mendez-Ferrer, S.;
Mikkers, H.;
Moore, K.;
Moreno, E.;
Mummery, E. L.;
Robin, C.;
Suda, T.;
Van Pel, M.;
Vanden Brink, G.;
Zwaginga, J. J.;
Fibbe, W. E.

Publication type:

Article

ICSBP promoter methylation in myelodysplastic syndromes and acute myeloid leukaemia.

Published in:

2011

By:

Otto, N.;
Göhring, G.;
Hofmann, W.;
Scherer, R.;
Luna, J. Chacon;
Lehmann, U.;
Ganser, A.;
Welte, K.;
Schlegelberger, B.;
Steinemann, D.

Publication type:

Letter

Efficacy of thalidomide- or lenalidomide-based therapy in proliferative multiple myeloma.

Published in:

2011

By:

Kapoor, P.;
Kumar, S.;
Mandrekar, S. J.;
Laumann, K. M.;
Dispenzieri, A.;
Lacy, M. Q.;
Dingli, D.;
Gertz, M. A.;
Kyle, R. A.;
Greipp, P. R.;
Rajkumar, S. V.;
Witzig, T. E.

Publication type:

Letter

Inhibition of eIF4E with ribavirin cooperates with common chemotherapies in primary acute myeloid leukemia specimens.

Published in:

2011

By:

Kraljacic, B. C.;
Arguello, M.;
Amri, A.;
Cormack, G.;
Borden, K.

Publication type:

Letter

Dissecting the role of SALL4, a newly identified stem cell factor, in chronic myelogenous leukemia.

Published in:

2011

By:

Lu, J.;
Ma, Y.;
Kong, N.;
Alipio, Z.;
Gao, C.;
Krause, D. S.;
Silberstein, L. E.;
Chai, L.

Publication type:

Letter

Mutations galore in myeloproliferative neoplasms: would the real Spartacus please stand up?

Published in:

2011

By:

Tefferi, A.

Publication type:

Editorial